Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics
Go back to Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics| (NASDAQ: NTLA) | Delayed: 12.79 +0.11 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.68 | 52 Week High | $30.40 | |||
| Open | $12.59 | 52 Week Low | $11.86 | |||
| Day High | $12.96 | P/E | N/A | |||
| Day Low | $12.52 | EPS | $0.00 | |||
| Volume | 1,564,656 | |||||

